Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Description:

This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.

Creator(s): Redhead, C. Stephen
Location(s): United States
Creation Date: March 10, 2004
Partner(s):
UNT Libraries Government Documents Department
Collection(s):
Congressional Research Service Reports
Usage:
Total Uses: 104
Past 30 days: 1
Yesterday: 0
Creator (Author):
Redhead, C. Stephen

Specialist in Life Sciences

Publisher Info:
Place of Publication: Washington D.C.
Date(s):
  • Creation: March 10, 2004
Coverage:
Place
United States
Description:

This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.

Physical Description:

6 pages.

Language(s):
Subject(s):
Partner:
UNT Libraries Government Documents Department
Collection:
Congressional Research Service Reports
Identifier:
Resource Type: Report
Format: Text